KRW 11870.0
(-2.63%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -108.91 Billion KRW | -191.01% |
2022 | -37.42 Billion KRW | 19.52% |
2021 | -46.5 Billion KRW | 30.48% |
2020 | -66.9 Billion KRW | -796.34% |
2019 | 9.6 Billion KRW | 334.39% |
2018 | -4.09 Billion KRW | 26.96% |
2017 | -5.61 Billion KRW | 52.0% |
2016 | -11.69 Billion KRW | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q2 | -29.5 Billion KRW | 64.06% |
2024 Q1 | -82.1 Billion KRW | 24.62% |
2023 Q2 | -80.47 Billion KRW | 46.12% |
2023 Q4 | -108.91 Billion KRW | 10.91% |
2023 Q3 | -122.25 Billion KRW | -51.93% |
2023 Q1 | -149.36 Billion KRW | -299.07% |
2023 FY | -108.91 Billion KRW | -191.01% |
2022 Q4 | -37.42 Billion KRW | 19.83% |
2022 Q3 | -46.68 Billion KRW | 42.0% |
2022 Q2 | -80.49 Billion KRW | -38.94% |
2022 Q1 | -57.92 Billion KRW | -24.56% |
2021 Q4 | -46.5 Billion KRW | -18.13% |
2021 Q3 | -39.36 Billion KRW | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
InBody Co.,Ltd | -16.2 Billion KRW | -572.096% |
Curexo Inc. | -15.03 Billion KRW | -624.546% |
Seegene, Inc. | -48.57 Billion KRW | -124.216% |
i-SENS, Inc. | 98.45 Billion KRW | 210.625% |
Ray Co., Ltd. | 67.09 Billion KRW | 262.334% |
Gencurix Inc. | 15.02 Billion KRW | 824.9% |
Sugentech Inc. | -6.95 Billion KRW | -1466.831% |
L&C Bio Co., Ltd | 67.18 Billion KRW | 262.117% |